57 phd-in-computer-vision-and-machine-learning Postdoctoral positions at Nature Careers in Denmark
Sort by
Refine Your Search
-
visit our homepage . Expectations and qualifications Applicants must hold an MSc, DVM, or MD degree, and a PhD, with research experience within one or more of the following areas: Clinical or molecular
-
, and nanomedicine. The postdoctoral researcher will collaborate closely with a PhD student and other younger students, contributing to a dynamic and supportive research environment. The candidate will
-
Applicants should hold a PhD degree in Biochemistry or Molecular Biology and have experience in protein O-GlcNAcylation modification field. Requirement: At least five years of research experience in fly
-
are searching for a highly motivated candidate who has: A PhD in a relevant field such as environmental management, geography, sociology, organization studies, political science, or related disciplines. The ideal
-
industrial and academic partners. The overall goal of the project is to optimize the design of water eletrolyzers for efficient green energy production. You will be conducting Computational Fluid Dynamic (CFD
-
characterization (e.g. NMR), biofilm extracellular polymeric substances, biophysics, glycoconjugates, complex assembly, or lectins, is an advantage. Your profile Applicants should hold a PhD in glycobiology
-
of scientific articles. Teaching is not required as part of this position. Daily work will be conducted in English, and familiarity with Danish is not necessary. Required qualifications PhD in pertinent field
-
will report to the Head of Department. In your daily job, you will report to Associate Professor Lasse Sommer Kristensen. Your competences You have academic qualifications at PhD level, preferably within
-
. There is a formalized teaching program dedicated to methodological aspects of pharmacoepidemiological research. As a department, we value having a pleasant and informal working environment across all job
-
guidance within the field tumor-immunology and cell therapy. The position focuses on in vivo reprogramming of immune cells using chimeric antigen receptor (CAR) constructs against glioblastoma. The position